Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes

European Journal of Clinical Investigation

Volumn 44, Issue 8, 2014, Pages 736-742

  Tseng, Chin Hsiao ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Diabetes; Epidemiology; Insulin; Taiwan; Thyroid cancer

Indexed keywords

HUMAN INSULIN; INSULIN GLARGINE; ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DOSE RESPONSE; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; TAIWAN; THYROID CANCER; TIME TO TREATMENT; TREATMENT DURATION; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; RISK FACTOR; THYROID TUMOR;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN, REGULAR, HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS;

EID: 84904573503     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12290     Document Type: Article

References (33)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
2. McNally RJ, Blakey K, James PW, Gomez Pozo B, Basta NO, Hale J. Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis. Eur J Epidemiol 2012;27:615-22.
3. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS; Taiwan Cancer Registry Task Force. Cancer trends in Taiwan. Jpn J Clin Oncol 2010;40:897-904.
4. IDF Diabetes Atlas Sixth edition. Available at: http://www.idf.org/diabetesatlas. Accessed on 8 March 2014.
5. Tseng CH, Tseng CP, Chong CK, Huang TP, Song YM, Chou CW et al. Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 2006;49:1755-60.
6. Tseng CH. The epidemiologic transition of diabetes mellitus in Taiwan: implications for reversal of female preponderance from a national cohort. Open Diabetes J 2009;2:18-23.
7. Ayturk S, Gursoy A, Kut A, Anil C, Nar A, Tutuncu NB. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol 2009;161:599-605.
8. Yasar HY, Ertuǧrul O, Ertuǧrul B, Ertuǧrul D, Sahin M. Insulin resistance in nodular thyroid disease. Endocr Res 2011;36:167-74.
9. Duran AO, Anil C, Gursoy A, Nar A, Altundag O, Tutuncu NB. The relationship between glucose metabolism disorders and malignant thyroid disease. Int J Clin Oncol 2013;18:585-9.
10. Völzke H, Friedrich N, Schipf S, Haring R, Lüdemann J, Nauck M et al. Association between serum insulin-like growth factor-I levels and thyroid disorders in a population-based study. J Clin Endocrinol Metab 2007;92:4039-45.
11. Shih SR, Chiu WY, Chang TC, Tseng CH. Diabetes and thyroid cancer risk: literature review. Exp Diabetes Res 2012;2012:578285.
12. Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R et al. The IGF system in thyroid cancer: new concepts. Mol Pathol 2001;54:121-4.
13. Tramontano D, Cushing GW, Moses AC, Ingbar SH. Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. Endocrinology 1986;119:940-2.
14. Bowker SL, Yasui Y, Veugelers P, Johnson JA. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia 2010;53:1631-7.
15. Janghorbani M, Dehghani M, Salehi-Marzijarani M. Systematic review and meta-analysis of insulin therapy and risk of cancer. Horm Cancer 2012;3:137-46.
16. Hsieh MC, Lee TC, Cheng SM, Tu ST, Yen MH, Tseng CH. The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese. Exp Diabetes Res 2012;2012:413782.
17. Malaguarnera R, Frasca F, Garozzo A, Gianì F, Pandini G, Vella V et al. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab 2011;96:766-74.
18. Kurtzhals P, Schäffer L, Sørensen A, Kristensen C, Jonassen I, Schmid C et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes 2000;49:999-1005.
19. Mannucci E, Monami M, Balzi D, Cresci B, Pala L, Melani C et al. Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients. Diabetes Care 2010;33:1997-2003.
20. Tseng CH. Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan. Diabetologia 2011;54:2009-15.
21. Tseng CH. Diabetes and risk of prostate cancer: a study using the National Health Insurance. Diabetes Care 2011;34:616-21.
22. Tseng CH. Thyroid cancer risk is not increased in diabetic patients. PLoS ONE 2012;7:e53096.
23. D'Agostino RB Jr. Propensity scores in cardiovascular research. Circulation 2007;115:2340-3.
24. Kitahara CM, Linet MS, Beane Freeman LE, Check DP, Church TR, Park Y et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control 2012;23:1615-24.
25. Kim HJ, Kim NK, Choi JH, Sohn SY, Kim SW, Jin SM et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) 2013;78:134-40.
26. Nikiforov YE. Radiation-induced thyroid cancer: what we have learned from chernobyl. Endocr Pathol 2006;17:307-17.
27. Belfiore A, La Rosa GL, La Porta GA, Giuffrida D, Milazzo G, Lupo L et al. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am J Med 1992;93:363-9.
28. Pellegriti G, De Vathaire F, Scollo C, Attard M, Giordano C, Arena S et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst 2009;101:1575-83.
29. Fernández-Navarro P, García-Pérez J, Ramis R, Boldo E, López-Abente G. Proximity to mining industry and cancer mortality. Sci Total Environ 2012;435-436:66-73.
30. Gerhard T. Bias: considerations for research practice. Am J Health Syst Pharm 2008;65:2159-68.
31. Müller K, Weidinger C, Führer D. Insulin glargine and insulin have identical effects on proliferation and phosphatidylinositol 3-kinase/AKT signalling in rat thyrocytes and human follicular thyroid cancer cells. Diabetologia 2010;53:1001-3.
32. Cheng TM. Taiwan's new national health insurance program: genesis and experience so far. Health Aff (Millwood) 2003;22:61-76.
33. Bureau of Health Promotion. Cancer Registry Annual Report 2008. Taiwan: Department of Health, Executive Yuan; 2010. Available at: http://www.bhp.doh.gov.tw/Download%5C97Statistics%5C1.%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%B9%B4%E5%BA%A6%E5%A0%B1%E5%91%8A%EF%BC%88%E5%85%A8%EF%BC%89/Y97-%E7%99%8C%E7%97%87%E7%99%BB%E8%A8%98%E5%B9%B4%E5%BA%A6%E5%A0%B1%E5%91%8A%EF%BC%88%E5%85%A8).pdf. Accessed on 27 June 2012.